English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Longitudinal and cross-sectional analysis of atrophy in pharmacoresistant temporal lobe epilepsy

Bernhardt, B. C., Worsley, K., Kim, H., Evans, A., Bernasconi, A., & Bernasconi, N. (2009). Longitudinal and cross-sectional analysis of atrophy in pharmacoresistant temporal lobe epilepsy. Neurology, 72(20), 1747-1754. doi:10.1212/01.wnl.0000345969.57574.f5.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Bernhardt, Boris C.1, Author              
Worsley, K.J.2, Author
Kim, H.1, Author
Evans, A.C.1, Author
Bernasconi, A.1, Author
Bernasconi, N.1, Author
Affiliations:
1Department of Neurology, Montreal Neurological Institute and Hospital, McGill University, Quebec, Canada., ou_persistent22              
2Department of Mathematics and Statistics, McGill University, Montreal, QC, Canada, ou_persistent22              

Content

show
hide
Free keywords: -
 Abstract: BACKGROUND:Whether recurrent epileptic seizures induce brain damage is debated. Disease progression in epilepsy has been evaluated only in a few community-based studies involving patients with seizures well controlled by medication. These studies concluded that epilepsy does not inevitably lead to global cerebral damage. OBJECTIVE:To track the progression of neocortical atrophy in pharmacoresistant temporal lobe epilepsy (TLE) using longitudinal and cross-sectional designs. METHODS: Using a fully automated measure of cortical thickness on MRI, we studied a homogeneous sample of patients with pharmacoresistant TLE. In the longitudinal analysis (n = 18), fixed-effect models were used to quantify cortical atrophy over a mean interscan interval of 2.5 years (range = 7 to 90 months). In the cross-sectional analysis (n = 121), we correlated epilepsy duration and thickness. To dissociate normal aging from pathologic progression, we compared aging effects in TLE to healthy controls. RESULTS: The longitudinal analysis mapped progression in ipsilateral temporopolar and central and contralateral orbitofrontal, insular, and angular regions. In patients with more than 14 years of disease, atrophy progressed more rapidly in frontocentral and parietal regions that in those with shorter duration. The cross-sectional study showed progressive atrophy in the mesial and superolateral frontal, and parietal cortices. CONCLUSIONS: Our combined cross-sectional and longitudinal analysis in patients with pharmacoresistant temporal lobe epilepsy demonstrated progressive neocortical atrophy over a mean interval of 2.5 years that is distinct from normal aging, likely representing seizure-induced damage. The cumulative character of atrophy underlies the importance of early surgical treatment in this group of patients.

Details

show
hide
Language(s):
 Dates: 2009-02-25
 Publication Status: Published online
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Neurology
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 72 (20) Sequence Number: - Start / End Page: 1747 - 1754 Identifier: -